Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Takada

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)Tomoya Kawaguchi, Masahiko Ando, Kazuhiro Asami, et al.
Anticancer Research|December 27, 2017
Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast CancerTsutomu Takashima, Hidemi Kawajiri, Takeo Nishimori, et al.
Anticancer Research|October 1, 2021
An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast CancerTsutomu Takashima, Shigehiko Nishimura, Hidemi Kawajiri, et al.
The Journal of Surgical Research|November 24, 2004
Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array dataKatsuhiko Murakawa, Mitsuhiro Tada, Minoru Takada, et al.
The Journal of Surgical Research|November 4, 2004
Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancerMinoru Takada, Mitsuhiro Tada, Eiji Tamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2004
[Subset analysis of data in the Japanese patients with NSCLC from IDEAL 1 study on gefitinib]Yutaka Nishiwaki, Seiji Yano, Tomohide Tamura, et al.
The Lancet. Oncology|December 22, 2009
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialTetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, et al.
The Journal of Surgical Research|April 12, 2005
Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasisKazuteru Komuro, Mitsuhiro Tada, Eiji Tamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancerEiji Tamoto, Mitsuhiro Tada, Katsuhiko Murakawa, et al.
The Journal of Surgical Research|April 12, 2005
Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profilingKen-ichi Teramoto, Mitsuhiro Tada, Eiji Tamoto, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)Tomoya Kawaguchi, Masahiko Ando, Kazuhiro Asami, et al.
Anticancer Research|December 27, 2017
Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast CancerTsutomu Takashima, Hidemi Kawajiri, Takeo Nishimori, et al.
Anticancer Research|October 1, 2021
An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast CancerTsutomu Takashima, Shigehiko Nishimura, Hidemi Kawajiri, et al.
The Journal of Surgical Research|November 24, 2004
Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array dataKatsuhiko Murakawa, Mitsuhiro Tada, Minoru Takada, et al.
The Journal of Surgical Research|November 4, 2004
Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancerMinoru Takada, Mitsuhiro Tada, Eiji Tamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2004
[Subset analysis of data in the Japanese patients with NSCLC from IDEAL 1 study on gefitinib]Yutaka Nishiwaki, Seiji Yano, Tomohide Tamura, et al.
The Lancet. Oncology|December 22, 2009
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialTetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, et al.
The Journal of Surgical Research|April 12, 2005
Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasisKazuteru Komuro, Mitsuhiro Tada, Eiji Tamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancerEiji Tamoto, Mitsuhiro Tada, Katsuhiko Murakawa, et al.
The Journal of Surgical Research|April 12, 2005
Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profilingKen-ichi Teramoto, Mitsuhiro Tada, Eiji Tamoto, et al.
Pageof 11